Radiation Benefits Mixed After Breast-Preserving Surgery

Share this article:
Radiation Benefits Mixed After Breast-Preserving Surgery
Radiation Benefits Mixed After Breast-Preserving Surgery

THURSDAY, Jan. 26 (HealthDay News) -- Treatment with radiation therapy after excision of ductal carcinoma in situ (DCIS) in women age 60 is associated with a slight improvement in survival, but may increase the likelihood of eventual mastectomy, according to a study published in the Feb. 1 issue of Cancer.

Rinaa S. Punglia, M.D., M.P.H., of the Dana-Farber Cancer Institute/Brigham and Women's Hospital in Boston, and colleagues studied the influence of treatment outcomes using a Markov decision model designed to simulate the clinical course of DCIS for a woman aged 60 who has undergone excision, with and without the addition of radiation therapy. They examined the risk of local recurrence, the likelihood of invasive disease, surgery choices after recurrence, and patient age at diagnosis in relation to treatment outcomes.

Using sensitivity analyses, the researchers found that radiation therapy after DCIS for a woman aged 60 improved overall disease-free survival by 2.1 months, while decreasing the chances of keeping both breasts by 8.6 percent; the latter decrease was due to a higher likelihood of eventual invasive recurrence or new breast cancer diagnosis requiring mastectomy. With increasing age at diagnosis, the difference in outcomes between the treatment strategies became smaller.

"Radiation for DCIS is prophylactic; it reduces the risk of invasive recurrence, which is the only lethal form of breast cancer, while increasing the probability of eventual mastectomy," the authors write. "The absolute magnitude of both effects is modest, such that personal patient preferences should drive decision making."

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Daily Oncology News

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Daily Oncology News

Unplanned hospitalizations among gastrointestinal cancer patients common

Unplanned hospitalizations among gastrointestinal cancer patients common

Among elderly patients with gastrointestinal cancer, unplanned hospitalizations are common, according to online research.

70-Gene signature not likely to be cost-effective for breast cancer

70-Gene signature not likely to be cost-effective for ...

Findings in comparative economic analysis of patients with node-negative breast cancer showed the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making.

Many clinicians feel mobile apps can improve patient outcomes

Many clinicians feel mobile apps can improve patient ...

Many physicians believe digital communication technologies, including mobile apps, can be of benefit to their patients.